F Femiano1, F Gombos, C Scully. 1. Stomatology Clinic, II University of Medicines and Surgery, Naples, Italy. femiano@libero.it
Abstract
BACKGROUND: The objective of this study was to investigate the effect of zinc on recurrent herpes labialis. MATERIALS/ METHODS: Twenty patients (12 females; median age 26.6 years) with a history of recurrent herpes labialis >6 episodes each year were treated with systemic zinc sulphate 22.5 mg twice daily for the months of February, March, September and October. All patients were followed for 12 months. RESULTS: Herpetic lesions reduced to <4 episodes (average 3) for the 12 months and the duration was <7 days for each episode (average 5.7). CONCLUSIONS: Systemic zinc sulphate appeared to reduce both the number of episodes and the time to recovery of herpes labialis.
BACKGROUND: The objective of this study was to investigate the effect of zinc on recurrent herpes labialis. MATERIALS/ METHODS: Twenty patients (12 females; median age 26.6 years) with a history of recurrent herpes labialis >6 episodes each year were treated with systemic zinc sulphate 22.5 mg twice daily for the months of February, March, September and October. All patients were followed for 12 months. RESULTS: Herpetic lesions reduced to <4 episodes (average 3) for the 12 months and the duration was <7 days for each episode (average 5.7). CONCLUSIONS: Systemic zinc sulphate appeared to reduce both the number of episodes and the time to recovery of herpes labialis.
Authors: Marlon Perera; John El Khoury; Vidyasagar Chinni; Damien Bolton; Liang Qu; Paul Johnson; Jason Trubiano; Christine F McDonald; Daryl Jones; Rinaldo Bellomo; Oneel Patel; Joseph Ischia Journal: BMJ Open Date: 2020-12-02 Impact factor: 2.692
Authors: Ingrid Urbancikova; Dana Hudackova; Juraj Majtan; Zuzana Rennerova; Peter Banovcin; Milos Jesenak Journal: Evid Based Complement Alternat Med Date: 2020-04-13 Impact factor: 2.629